Atlas Trials

Effects of Lemborexant as a Treatment for Moderate-to-severe OSA Patients With Low Arousal Threshold

Clinical trial NCT05763329 · COMPLETED

Trial details

NCT number
NCT05763329
Sponsor
Chulalongkorn University
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
OSA
Start date
2023-02-01
Primary completion
2025-02-28
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.